← All trials
NCT07251413
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 22, 2025
- Primary completion
- Dec 31, 2028
- Completion date
- Dec 31, 2028
- First posted
- Nov 26, 2025
- Last posted
- Nov 26, 2025
- Enrollment
- 18
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institute of Oncology Dr. Rosell (IOR)Lead sponsor
- RegeneronCollaborator
- University of BarcelonaOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.